Trending...
- Templeton Global Income Fund Announces Update on Investment Adviser Transition to Saba Capital
- LI-CYCLE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Li-Cycle To Contact Him Directly To Discuss Their Options
- Hustle and Threads Unveils a Collection of Inspiring Goods to Ignite Entrepreneurial Spirits
FAYETTEVILLE, Ark. - Nyenta -- Health Canada has issued a licence on Lineus Medical's flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, peripherally inserted central catheters, central venous catheters, midlines, IV ports, and interosseous vascular access devices on patients two weeks of age and up. This licence makes Lineus Medical the first company in the world to obtain authorization for the use of a break-away device on all vascular access lines and for both pediatric and adult patients in a country.
SafeBreak Vascular is the only breakaway device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on Nyenta.com
Will Armstrong, COO of Lineus Medical stated, "This has been a year of growth for the company. This past May, SafeBreak received pediatric clearance for peripheral IVs from the US Food and Drug Administration, and now we are licenced on all lines for children and adults in Canada. We look forward to making SafeBreak available to every hospital and the over 38 million people living in Canada."
Vance Clement, CEO of Lineus Medical, stated, "Lineus Medical is the first company to obtain licence in a country on the full array of vascular lines across pediatric to adult aged patients. Not only are we expanding into every clinical setting including, Emergency Medical Services, veterinary care, and acute care hospitals systems, we are expanding internationally. Every patient, no matter where they live in the world, deserves a SafeBreak on their IV line."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on Nyenta.com
1. Data on File
MKG-0230 Rev 00
SafeBreak Vascular is the only breakaway device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on Nyenta.com
- DellaRatta, Van Zandt, Maté, Hedges and other big names WIN BIG at Jazz for Peace Comedy NFT Awards!
- Kasuri Hosts Launch Of Bespoke Jewelry Line By Hudson Based Trans Artist
- New York Junior League Announces its 2024 Outstanding Sustainers and Outstanding Volunteers to Be
- Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Dollar General Corporation (DG) Investors
- Rochester: Updates on Pulaski Building Fire
Will Armstrong, COO of Lineus Medical stated, "This has been a year of growth for the company. This past May, SafeBreak received pediatric clearance for peripheral IVs from the US Food and Drug Administration, and now we are licenced on all lines for children and adults in Canada. We look forward to making SafeBreak available to every hospital and the over 38 million people living in Canada."
Vance Clement, CEO of Lineus Medical, stated, "Lineus Medical is the first company to obtain licence in a country on the full array of vascular lines across pediatric to adult aged patients. Not only are we expanding into every clinical setting including, Emergency Medical Services, veterinary care, and acute care hospitals systems, we are expanding internationally. Every patient, no matter where they live in the world, deserves a SafeBreak on their IV line."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on Nyenta.com
- Cboe Global Markets to Present at the Goldman Sachs 2023 U.S. Financial Services Conference Wednesday, December 6
- Dominating Business Intelligence: Informer Tops the BI & Analytics Survey for the Fourth Time
- Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
- BOGNER Establishes Permanent Retail Presence in the US with Bicoastal Flagship Stores
- Bragoli & Associates Announces Winner of Volunteerism Scholarship To North Babylon High School St
1. Data on File
MKG-0230 Rev 00
Source: Lineus Medical
Filed Under: Health, Technology
0 Comments
Latest on Nyenta.com
- A Culinary Haven in Little Caribbean, Brooklyn, Captures Hearts and Palates
- New Book 'The Kelsey Outrage' by Alison Hubbard Launching January 25th, 2024
- The Dog Gurus Bring Light to Mysterious Respiratory Illness in Dogs
- Sphere To Feature First-Of-Its-Kind Exosphere Activation With The Radio City Rockettes This Holiday Season
- Miss Grass Launches "Faces Of Cannabis" to Dismantle Harmful Stereotypes of the Cannabis Community
- SMBC Hires Paul Burke to Lead New Capital Solutions Group
- National Widowers Organization Announces Appointment of Eric Washington to the Board of Directors
- GYMGUYZ Forges B2B Partnerships Nationwide, Making Fitness Routines Accessible Anywhere
- The Samuel Lawrence Foundation Presents Live from Dubai: First Friday Series Webinar on Dec 1
- Wohler makes the Evertz Quartz Protocol available for their iAM-SUM audio monitors & iVAM-SUM AV monitors
- Genuine Hospitality, LLC Adds Two, Southwest Florida Hotels, to Growing Portfolio
- 2024 is around the corner for Independent Pharmacies
- The CPSE Shenzhen 2023 was inaugurated on October
- SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO)
- Delisting and Cancellation of Trading From the London Stock Exchange
- KX LAUNCHES KDB.AI SERVER EDITION FOR ENTERPRISE-SCALE GENERATIVE AI USA - English USA - English India - English
- The Single Domain Antibody Revolution
- Holiday Market Opens at the New Rochelle Train Station
- Breast Cancer Survivor Unveils Groundbreaking Mentoring Program Empowering Virtual Assistants
- Labaton Sucharow LLP Announces Securities Class Action Lawsuit Filed Against Roblox Corporation and Certain Executives